Vladimir Bruno

Hi Vladimir, saw Surevix's deal-by-deal approach to specialty pharmacy and lower-middle-market healthcare control buys. I build origination infrastructure for lean acquisition teams, especially when the market is too fragmented to wait for bankers. Would it be crazy to compare notes?

Thanks Vladimir - good to connect. Are you finding enough independent healthcare services owners for Surevix right now, or is that pipeline still fairly manual?